文献速递头颈外科

探讨p16状态、化疗方案及其他营养指标对头颈癌患者胃造瘘预测的作用

Investigation of p16 status, chemotherapy regimen, and other nutrition markers for predicting gastrostomy in patients with head and neck cancer.
PubMed 文献 · Head Neck · 2017-02-23

该研究纳入2010年7月至2011年6月接受根治性治疗的头颈癌患者269例,分析p16状态、化疗方案及营养指标与预防性胃造瘘需求的关系。现行方案正确识别88例高危患者中的81例(92%),但将181例低风险患者中的32例(18%)错误分类。在低风险的口腔或口咽癌患者中,p16阳性者需胃造瘘的比值比为4.4(p=0.049),有营养不良风险者比值比为4.5(p=0.019)。

要点

  • 现行方案识别高危患者需胃造瘘的准确率为92%(81/88),低风险患者误判率为18%(32/181)。
  • 低风险口腔或口咽癌患者中,p16阳性者需胃造瘘的比值比为4.4(p=0.049)。
  • 低风险口腔或口咽癌患者中,有营养不良风险者需胃造瘘的比值比为4.5(p=0.019)。

核心结论

  • 营养不良风险和p16状态可用于识别可能从预防性胃造瘘中获益的更多患者。

研究设计与样本

  • 研究纳入2010年7月至2011年6月接受根治性治疗的头颈癌患者269例,分析年龄、性别、肿瘤部位、分期、治疗、p16状态、白蛋白、营养不良筛查工具(MST)评分等变量与方案风险评级及预防性胃造瘘需求之间的关系。

主要发现

  • 现行方案正确识别88例高危患者中的81例(92%)需胃造瘘,但将181例低风险患者中的32例(18%)错误分类。
  • 在低风险的口腔或口咽癌患者中,p16阳性者需胃造瘘的比值比为4.4(p=0.049)。
  • 在低风险的口腔或口咽癌患者中,有营养不良风险者需胃造瘘的比值比为4.5(p=0.019)。

临床怎么用

  • 作者认为,营养不良风险和p16状态可用于识别可能从预防性胃造瘘中获益的更多患者。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The purpose of this study was to determine if p16 status, chemotherapy regimen, or other nutrition markers could improve protocol accuracy in predicting proactive gastrostomy in patients with head and neck cancer. METHODS: Patients who received curative treatment from July 2010 to June 2011 were included (n = 269). Associations among dependent variables (age, sex, tumor site, staging, treatment, p16 status, albumin, and Malnutrition Screening Tool [MST] score), the protocol risk rating, and requirement for proactive gastrostomy were examined. RESULTS: Current protocol correctly identified 81 of 88 high-risk patients (92%) for gastrostomy, but incorrectly classified 32 of 181 low-risk patients (18%). Analysis of low-risk patients with oral or oropharyngeal cancers, found p16-positive disease had 4.4 times greater odds (p = .049), and those at risk of malnutrition had 4.5 times greater odds (p = .019) of requiring gastrostomy. CONCLUSION: Malnutrition risk and p16 status could be used to identify further patients who may benefit from proactive gastrostomy. © 2017 Wiley Periodicals, Inc. Head Neck 39: 868-875, 2017.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Brown TE, Wittholz K, Way M, et al. Investigation of p16 status, chemotherapy regimen, and other nutrition markers for predicting gastrostomy in patients with head and neck cancer. Head Neck. 2017. PMID: 28230929. doi:10.1002/hed.24630

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。